Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.
Department of Nuclear Medicine, University Hospital, Zurich, Switzerland.
Eur Heart J Cardiovasc Imaging. 2022 Mar 22;23(4):e136-e161. doi: 10.1093/ehjci/jeab292.
Cardiac computed tomography (CT) was initially developed as a non-invasive diagnostic tool to detect and quantify coronary stenosis. Thanks to the rapid technological development, cardiac CT has become a comprehensive imaging modality which offers anatomical and functional information to guide patient management. This is the second of two complementary documents endorsed by the European Association of Cardiovascular Imaging aiming to give updated indications on the appropriate use of cardiac CT in different clinical scenarios. In this article, emerging CT technologies and biomarkers, such as CT-derived fractional flow reserve, perfusion imaging, and pericoronary adipose tissue attenuation, are described. In addition, the role of cardiac CT in the evaluation of atherosclerotic plaque, cardiomyopathies, structural heart disease, and congenital heart disease is revised.
心脏计算机断层扫描(CT)最初是作为一种非侵入性诊断工具开发的,用于检测和量化冠状动脉狭窄。得益于快速的技术发展,心脏 CT 已成为一种综合成像方式,可提供解剖和功能信息以指导患者管理。这是由欧洲心血管成像协会认可的两份互补文件中的第二份,旨在提供有关在不同临床情况下适当使用心脏 CT 的最新适应症。本文介绍了新兴的 CT 技术和生物标志物,例如 CT 衍生的血流储备分数、灌注成像和冠状动脉脂肪组织衰减。此外,还回顾了心脏 CT 在评估动脉粥样硬化斑块、心肌病、结构性心脏病和先天性心脏病中的作用。